Site-Specific Mutagenesis of the Human Interleukin-2 Gene: Structure-Function Analysis of the Cysteine Residues
- 29 June 1984
- journal article
- research article
- Published by American Association for the Advancement of Science (AAAS) in Science
- Vol. 224 (4656) , 1431-1433
- https://doi.org/10.1126/science.6427925
Abstract
The gene encoding human interleukin-2 (IL-2) has been cloned from human spleen cells, peripheral blood lymphocytes, and the Jurkat cell line. Nucleotide sequence analysis of the gene revealed that the encoded IL-2 protein has three cysteines located at amino acid residues 58, 105, and 125 of the mature protein. Site-specific mutagenesis procedures were used to modify the IL-2 gene by changing each of the cysteine codons individually to serine codons. Substitution of serine for cysteine residues at either position 58 or 105 of the IL-2 protein substantially reduced biological activity, indicating that the cysteines at these positions are necessary for maintenance of the biologically active conformation and may therefore be linked by a disulfide bridge. The modified IL-2 protein containing a substitution at position 125 retained full biological activity, suggesting that the cysteine at this position is not involved in a disulfide bond and that a free sulfhydryl group at that position is not necessary for receptor binding.Keywords
This publication has 26 references indexed in Scilit:
- Biological Activity of Recombinant Human Interleukin-2 Produced in Escherichia coliScience, 1984
- Interleukin-2 enhances the depressed natural killer and cytomegalovirus-specific cytotoxic activities of lymphocytes from patients with the acquired immune deficiency syndrome.Journal of Clinical Investigation, 1983
- Structure and expression of a cloned cDNA for human interleukin-2Nature, 1983
- Purification of human interleukin 2 to apparent homogeneity and its molecular heterogeneity.The Journal of Experimental Medicine, 1982
- Lymphokine-activated killer cell phenomenon. Lysis of natural killer-resistant fresh solid tumor cells by interleukin 2-activated autologous human peripheral blood lymphocytes.The Journal of Experimental Medicine, 1982
- Construction of a functional human suppressor tRNA gene: an approach to gene therapy for β-thalassaemiaNature, 1982
- Interleukin-2 augments natural killer cell activityNature, 1981
- Interleukin 2 in cell‐mediated immune responsesJournal of Supramolecular Structure, 1980
- Selective in Vitro Growth of T Lymphocytes from Normal Human Bone MarrowsScience, 1976
- Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4Nature, 1970